Search Results - Luke Maggs
- Showing 1 - 5 results of 5
-
1
-
2
239 CSPG4-targeted CAR T cells demonstrate potent antitumor activity in an orthotopic murine model of anaplastic thyroid cancer by Cristina R Ferrone, Soldano Ferrone, Giulia Cattaneo, Marco Ventin, Venkata Rao Vantaku, Shahrzad Arya, Jingyu Jia, Luke Maggs, Xinhui Wang, Sareh Parangi
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
3
The number of CD56dim NK cells in the graft has a major impact on risk of disease relapse following allo-HSCT by Luke Maggs, Francesca Kinsella, Y. L. Tracey Chan, Suzy Eldershaw, Duncan Murray, Jane Nunnick, Joanne Bird, Charles Craddock, Jianmin Zuo, Ram Malladi, Paul Moss
Published in Blood Advances (2017-08-01)Get full text
Article -
4
B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer by Giulia Cattaneo, Marco Ventin, Shahrzad Arya, Cedric Bailey, Venkata Rao Vantaku, Jingyu Jia, Maoyang Qi, Luke Maggs, Xinhui Wang, Sareh Parangi, Soldano Ferrone, Cristina R. Ferrone
Published in Journal of Experimental & Clinical Cancer Research (2025-08-01)Get full text
Article -
5
317 B7-H3-targeted CAR T cell with an inducible caspase 9 suicide gene effectively eradicates uveal melanoma liver metastases by Yi Sun, Cristina R Ferrone, Rizwan Haq, Soldano Ferrone, Genevieve M Boland, Sandra Ryeom, Russell W Jenkins, Giulia Cattaneo, Marco Ventin, Shahrzad Arya, Jingyu Jia, Luke Maggs, Xinhui Wang, Bruce R Ksander
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article
